Plus Therapeutics, Inc. (PSTV)
NASDAQ: PSTV · Real-Time Price · USD
4.200
-0.060 (-1.41%)
At close: Jun 26, 2026, 4:00 PM EDT
4.160
-0.040 (-0.95%)
After-hours: Jun 26, 2026, 7:41 PM EDT
Plus Therapeutics Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Plus Therapeutics stock have an average target of 36, with a low estimate of 12 and a high estimate of 57. The average target predicts an increase of 757.14% from the current stock price of 4.20.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Plus Therapeutics stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 4 | 3 | 3 | 3 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 1 | 1 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 5 | 5 | 5 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Ascendiant | Ascendiant | Buy Maintains $65 → $57 | Buy | Maintains | $65 → $57 | +1,257.14% | Jun 6, 2026 |
| Maxim Group | Maxim Group | Buy Maintains $12 | Buy | Maintains | $12 | +185.71% | May 20, 2026 |
| Lake Street | Lake Street | Buy Maintains $50 | Buy | Maintains | $50 | +1,090.48% | May 19, 2026 |
| D. Boral Capital | D. Boral Capital | Hold Downgrades n/a | Hold | Downgrades | n/a | n/a | Mar 31, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $25 | Buy | Reiterates | $25 | +495.24% | Mar 16, 2026 |
Financial Forecast
Revenue This Year
6.30M
from 5.21M
Increased by 20.76%
Revenue Next Year
19.14M
from 6.30M
Increased by 204.05%
EPS This Year
-3.92
from -0.29
EPS Next Year
-2.40
from -3.92
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 10.5M | 28.0M | |
| Avg | 6.3M | 19.1M | |
| Low | 4.0M | 10.0M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 102.0% | 344.8% | |
| Avg | 20.8% | 204.1% | |
| Low | -23.3% | 58.8% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -3.39 | -1.98 | |
| Avg | -3.92 | -2.40 | |
| Low | -4.78 | -2.81 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.